Can-Fite publishes study results on canine osteoarthritis drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. SNOW
10. USO

Go back to Can-Fite publishes study results on canine osteoarthritis drug
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 2.36 -0.93 (28.27%)
Previous Close $3.29    52 Week High $3.89 
Open $2.78    52 Week Low $1.85 
Day High $2.78    P/E N/A 
Day Low $2.32    EPS $0.00 
Volume 20,257,099       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206